v3.20.1
Consolidated Balance Sheets - USD ($)
Mar. 31, 2020
Dec. 31, 2019
Current Assets    
Cash and cash equivalents $ 20,738,776 $ 9,039,887
Short-term investments 5,706,082 5,713,922
Accounts receivable 144,119 34,986
Prepaid expenses and other current assets 537,653 420,328
Total Current Assets 27,126,630 15,209,123
Property and Equipment, net 705,553 559,410
Other Assets    
In-process R&D 5,866,000 5,866,000
Goodwill 1,452,338 1,452,338
Operating lease right-of-use asset 2,211,506 2,287,500
Finance lease right-of-use asset 336,368 187,573
Deposits 122,905 394,637
Total Other Assets 9,989,117 10,188,048
Total Assets 37,821,300 25,956,581
Current Liabilities    
Accounts payable 1,350,476 1,503,342
Deferred revenue, current portion 2,508,809 3,410,319
Contingent consideration, current portion 1,659,000 1,579,334
Operating lease liability, current portion 222,752 216,832
Finance lease liability, current portion 103,269 49,104
Accrued expenses and other liabilities 1,092,235 1,676,467
Total Current Liabilities 6,936,541 8,435,398
Long Term Liabilities    
Other long-term liabilities 14,216  
Derivative warrant liability 41,360  
Deferred tax liability 361,911 361,911
Deferred revenue, net of current portion 200,000 200,000
Operating lease liability, net of current portion 1,462,005 1,519,574
Financing lease liability, net of current portion 241,938 142,667
Contingent consideration, net of current portion 2,032,515 2,139,181
Total Liabilities 11,290,486 12,798,731
Commitments and Contingencies (Note 9 and 13)
Stockholders' Equity    
Common stock, $.0002 par value; 100,000,000 shares authorized, 77,924,516 and 33,785,999 shares issued and outstanding at March 31, 2020 and December 31, 2019, respectively 15,627 6,757
Additional paid-in capital 137,692,553 118,173,843
Accumulated deficit (110,889,854) (104,597,748)
Accumulated other comprehensive income (loss) 207,554 (11,250)
Total Stockholders' Equity - Heat Biologics, Inc. 27,025,880 13,571,602
Non-Controlling Interest (495,066) (413,752)
Total Stockholders' Equity 26,530,814 13,157,850
Total Liabilities and Stockholders' Equity $ 37,821,300 $ 25,956,581

Source